Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Cardiol. Feb 26, 2026; 18(2): 114636
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114636

Full Size Figure Download Figure

Figure 3 Kaplan-Meier curves for cumulative major adverse cardiac event-free survival rate. MACE: Major adverse cardiac event.

Citation: Trehan VK, Safal S, Trehan S, Kathuria S, Vani PS. Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy. World J Cardiol 2026; 18(2): 114636
URL: https://www.wjgnet.com/1949-8462/full/v18/i2/114636.htm
DOI: https://dx.doi.org/10.4330/wjc.v18.i2.114636

Trehan VK, Safal S, Trehan S, Kathuria S, Vani PS. Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy. World J Cardiol 2026; 18(2): 114636 [PMID: 41694037 DOI: 10.4330/wjc.v18.i2.114636]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.